Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
نویسندگان
چکیده
Vaginal dryness is a common condition that is particularly prevalent during and after the menopause, and is one of the symptoms of vulvovaginal atrophy/genitourinary syndrome of menopause. The impact of vaginal dryness on interpersonal relationships, quality of life, daily activities, and sexual function can be significant, but is frequently underestimated. Furthermore, barriers exist to treatment-seeking, and this condition is often underreported and undertreated. Greater education about vaginal dryness and the range of available treatments is essential to encourage more women to seek help for this condition. Personal lubricants and moisturizers are effective at relieving discomfort and pain during sexual intercourse for women with mild to moderate vaginal dryness, particularly those who have a genuine contraindication to estrogen, or who choose not to use estrogen. However, there is a distinction between lubricants and moisturizers, and notable differences between commercially available products. Women should be advised to choose a product that is optimally balanced in terms of both osmolality and pH, and is physiologically most similar to natural vaginal secretions. A series of recommendations for the use of vaginal lubricants and moisturizers, either on their own or in combination with systemic or topical hormone replacement therapy, is presented.
منابع مشابه
Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
OBJECTIVE To comprehensively review and critically assess the literature on vaginal estrogen and its alternatives for women with genitourinary syndrome of menopause and to provide clinical practice guidelines. DATA SOURCES MEDLINE and Cochrane databases were searched from inception to April 2013. We included randomized controlled trials and prospective comparative studies. Interventions and c...
متن کاملTreating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy
Vulvovaginal atrophy (VVA) and dryness are common symptoms of the decline in endogenous production of estrogen at menopause and often result in dyspareunia. Yet while 10% to 40% of women experience discomfort due to VVA, it is estimated that only 25% seek medical help. The main goals of treatment for vaginal atrophy are to improve symptoms and to restore vaginal and vulvar anatomic changes. Tre...
متن کاملCO2 Laser Treatment is Effective for Symptoms of Vaginal Atrophy: No.
GENITOURINARY syndrome of menopause (GSM), preablative CO laser. After the third treatment paviously known as vulvovaginal atrophy (VVA), is a condition affecting postmenopausal women, often characterized by vaginal dryness, burning, itching, irritation, dysuria and dyspareunia. Therapies range fromvaginalmoisturizers to lowdose topical estrogen, and selective estrogen receptor modulators. Cost...
متن کاملNew therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency
OBJECTIVE To evaluate the clinical response of patients with symptoms of genitourinary syndrome of menopause after application of microablative fractional radiofrequency in the vagina and vaginal introitus. METHODS Fourteen patients with symptoms of genitourinary syndrome of menopause underwent three applications of microablative fractional radiofrequency with a 30-day interval, using the Wav...
متن کاملMultidisciplinary Overview of Vaginal Atrophy and Associated Genitourinary Symptoms in Postmenopausal Women
INTRODUCTION Vaginal atrophy, which may affect up to 45% of postmenopausal women, is often associated with one or more urinary symptoms, including urgency, increased frequency, nocturia, dysuria, incontinence, and recurrent urinary tract infection. AIMS To provide an overview of the current literature regarding cellular and clinical aspects of vaginal atrophy and response to treatment with lo...
متن کامل